Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

J Clin Psychopharmacol. 2015 Oct;35(5):609-11. doi: 10.1097/JCP.0000000000000373.

Authors

Anthony P Turel¹, Keun Hee Oh, Ian S Zagon, Patricia J McLaughlin

Affiliation

¹ Department of Neurology The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Pxm9@psu.edu.

PMID: 26203498
DOI: 10.1097/JCP.0000000000000373

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / physiopathology
Naltrexone / administration & dosage*
Naltrexone / adverse effects
Naltrexone / therapeutic use
Narcotic Antagonists / administration & dosage*
Narcotic Antagonists / adverse effects
Narcotic Antagonists / therapeutic use
Retrospective Studies
Treatment Outcome
Young Adult

Substances

Narcotic Antagonists
Naltrexone